Elon Musk’s brain-chip startup, Neuralink, has secured the United States Food and Drug Administration’s (FDA) coveted “Breakthrough Device” designation for its experimental brain implant, Blindsight. This milestone marks a significant leap forward in Neuralink’s mission to restore vision in individuals with complete or partial blindness, including those with non-functional optic nerves. The FDA’s breakthrough designation...The post Elon Musk’s Neuralink Receives FDA Approval For Revolutionary Brain Implant first appeared on New Telegraph.The post Elon Musk’s Neuralink Receives FDA Approval For Revolutionary Brain Implant appeared first on New Telegraph.
Related Articles
Don't miss out on breaking stories and in-depth articles.